Viewing Study NCT01596218


Ignite Creation Date: 2025-12-25 @ 4:58 AM
Ignite Modification Date: 2025-12-26 @ 3:57 AM
Study NCT ID: NCT01596218
Status: COMPLETED
Last Update Posted: 2018-07-26
First Post: 2012-05-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Brentuximab Vedotin for Steroid Refractory GvHD
Sponsor: Massachusetts General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module